A comparison of the safety and efficacy of brimonidine 0.2% bid versus tid, in subjects with elevated intraocular pressure

被引：0

作者：

Rosenthal, AL ^{[1
]}

Walters, T ^{[1
]}

Berg, E ^{[1
]}

Safyan, E ^{[1
]}

Batoosingh, AL ^{[1
]}

机构：

[1] ALLERGAN PHARMACEUT INC,OPHTHALMOL CLIN RES,IRVINE,CA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1996年 / 37卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：5071 / 5071

页数：1

共 50 条

[1] A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure
Serle, JB
SURVEY OF OPHTHALMOLOGY, 1996, 41 : S39 - S47
[2] A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% suspension in subjects with elevated intraocular pressure
Serle, JB
Abelson, M
Chen, K
Dirks, M
Forester, R
Masi, R
Mundorf, T
Ostrov, C
Parver, L
Sherwood, M
Spirin, F
Stewart, W
Walters, T
SOE '97 - XI CONGRESS OF THE EUROPEAN SOCIETY OF OPHTHALMOLOGY, VOLS 1 AND 2, 1997, : 521 - 526
[3] A 3-month comparison of efficacy and safety of brimonidine-tartrate 0.2% timolol 0.5% fixed combination (BID) with timolol 0.5% (BID) or brimonidine-tartrate 0.2% (TID)
Craven, ER
Choplin, N
Larsen, C
Olson, M
Whitcup, S
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U54 - U54
[4] The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%
Stewart, WC
Stewart, JA
Day, DG
Jenkins, J
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2004, 82 (02): : 161 - 165
[5] The safety and efficacy of unoprostone isopropyl 0.15% versus brimonidine 0.2%
Schur, J
Stewart, JA
Day, DG
Leech, JN
Stewart, WC
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U969 - U969
[6] A 3-month comparison of brimonidine-purite 0.15% BID with brimonidine 0.2% BID in patients successfully treated with brimonidine 0.20% BID
Williams, RD
Dirks, M
Batoosingh, AL
Felix, C
Whitcup, SM
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U55 - U55
[7] Efficacy of brimonidine 0.2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification
Katsimpris, JM
Siganos, D
Konstas, AGP
Kozobolis, V
Georgiadis, N
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2003, 29 (12): : 2288 - 2294
[8] Comparison of latanoprost and unoprostone in subjects with elevated intraocular pressure
Jampel, HD
Bacharach, J
Wohl, LG
Sheu, WP
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1165 - U1165
[9] Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25% suspension in patients with elevated intraocular pressure
Cantor, LB
Hoop, J
Katz, LJ
Flartey, K
CLINICAL THERAPEUTICS, 2001, 23 (07) : 1032 - 1039
[10] Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension
Katz, L. Jay
Simmons, Steven T.
Craven, E. Randy
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (12) : 2971 - 2983

← 1 2 3 4 5 →